Financial Management Professionals’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Financial Management Professionals’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-846	Closed	-$45K	–	448
2016 Q1	$45K	Hold	846	–	–	0.02%	75
2015 Q4	$55K	Hold	846	–	–	0.03%	71
2015 Q3	$48K	Hold	846	–	–	0.03%	85
2015 Q2	$49K	Buy	+846	New	+$52.2K	0.02%	86
2014 Q2	–	Sell	-846	Closed	-$45K	–	264
2014 Q1	$45K	Hold	846	–	–	0.03%	89
2013 Q4	$34K	Hold	846	–	–	0.02%	105
2013 Q3	$32K	Hold	846	–	–	0.02%	111
2013 Q2	$33K	Buy	+846	New	+$32.9K	0.02%	105

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Financial Management Professionals's TEVA Position: Q2 2016 in Review

Financial Management Professionals sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2016, closing a stake of 846 shares — an estimated $45K sold.

Financial Management Professionals first reported a position in TEVA in Q2 2013 and held it in 8 quarters. The position peaked at $55K in Q4 2015. 813 funds tracked by Wall St. Rank hold TEVA as of Q2 2016.

Financial Management Professionals reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2016 after selling out during the quarter.
Financial Management Professionals sold 846 Teva Pharmaceutical Industries Limited shares in Q2 2016, an estimated $45K.
Financial Management Professionals first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 8 quarters.
Financial Management Professionals's Teva Pharmaceutical Industries Limited position peaked at $55K in Q4 2015.
813 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2016.

Based on Financial Management Professionals's 13F filing for Q2 2016, filed 4 Aug 2016.